AbbVie ends 11-year Calico partnership focused on aging research
FierceBiotech - 12-Nov-2025AbbVie ends its $1.75B Calico deal after the ALS drug fosigotifator failed in phase 2/3 trials
FierceBiotech
Web resource providing the latest biotech news, articles, and resources related to biotech company news
Biopharma is a fast-growing world where big ideas come along daily. Our readers rely on Fierce Biotech for the latest news, analysis and data on drugs and the companies that make them. Fierce Biotech covers the biopharma waterfront, from drug development through the entire lifecycle—tracking regulatory approvals, payer negotiations, manufacturing, marketing, patent fights, government investigations and regulation, M&A deals and beyond. Our aim is to analyze the day's news, showing readers not only what they need to know, but why they need to know it. Beyond the daily, the Fierce Biotech team produces special reports that take stock of the industry's products and finances, and shed new light on industry trends.
Visit website: https://www.fiercebiotech.com/
Details last updated 08-Feb-2019
People at FierceBiotech
Helen Floersh
Writer at Fierce Biotech, covering developments in basic science research and early-stage drug development.
Articles sourced from FierceBiotech
Inbrain teams with Microsoft to advance AI-powered brain implants
FierceBiotech - 11-Nov-2025Graphene-based BCIs use Azure AI to adapt in real time for Parkinson’s and stroke therapy
Roche taps Manifold Bio to cross the brain barrier
FierceBiotech - 03-Nov-2025$2B deal aims to develop AI-guided shuttles to carry therapies across the blood-brain barrier
Takeda partners with Nabla Bio to speed up drug discovery using AI
FierceBiotech - 14-Oct-2025Their goal is to make treatments faster, safer, and more effective
Regeneron’s gene therapy helps kids hear naturally again
FierceBiotech - 12-Oct-2025Early results show hope for future hearing loss treatments
Ronovo secures $67M to expand modular robotic surgery platform
FierceBiotech - 09-Sep-2025Backed by J&J, Carina robot gains traction in China with global approvals on the horizon
Genentech ends $2b cancer cell therapy pact with Adaptive
FierceBiotech - 18-Aug-2025Pharma giant retreats from costly cell therapy deals amid layoffs and R&D cuts
Synchron’s brain implant lets an ALS patient control an iPad entirely through thought
FierceBiotech - 04-Aug-2025This breakthrough shows how technology can restore independence
Chugai, Gero ink $250m deal to target ageing
FierceBiotech - 07-Jul-2025Gero’s AI will uncover ageing targets; Chugai will develop antibody drugs to treat related diseases
Calico taps Mabwell’s anti-ageing antibody in $596m licensing deal
FierceBiotech - 26-Jun-2025Alphabet's Calico licenses IL-11 drug to target age-related diseases beyond China
Splicebio raises $135m to advance gene therapy for eye disease
FierceBiotech - 11-Jun-2025SB-007 enters phase 1/2 trials to restore vision in Stargardt disease using novel splicing tech
Boundless bio cuts staff and rethinks strategy after lead drug fails in early trials
FierceBiotech - 27-May-2025Biotech pivots to drug combo after monotherapy safety and efficacy setbacks
Lilly bets big on AI-discovered ALS drug in $415m deal
FierceBiotech - 06-May-2025AI-powered therapy offers new hope for ALS as early trials approach
Biotech shake-up: Unity and Mammoth announce major layoffs amid strategic shifts
FierceBiotech - 05-May-2025Unity exits eye drug race, Mammoth tightens focus on CRISPR pipeline
Biolinq secures $100m to launch needle-free glucose monitor
FierceBiotech - 22-Apr-2025Tracks glucose, activity, and sleep—offering a simpler option for people with Type 2 diabetes
New UK clinical trial laws aim for faster research approvals
FierceBiotech - 14-Apr-2025New funding and better access are part of efforts to make Britain leader in medical innovation
Isomorphic Labs secures $600m to supercharge AI drug discovery
FierceBiotech - 31-Mar-2025Backed by Nobel science, the Alphabet spinout speeds up AI drug development
Bit.bio cuts 25% of staff as it shifts from therapy development to lab research
FierceBiotech - 19-Mar-2025Company aims to grow its product line and biotech partnerships
Vertex ends gene editing deal with Verve amid R&D shift
FierceBiotech - 27-Feb-2025Verve regains full rights to its liver disease program as it moves forward independently
Gene therapy restores hearing in children with rare deafness
FierceBiotech - 24-Feb-2025Regeneron’s DB-OTO offers new hope for genetic hearing loss
Display all articles
